HCA Q1 revenue up 4.3% to $19.1B; EPS rises 10.9% to $7.15; declares $0.78 dividend

HCA Healthcare, Inc.

2026-Q1 EPS reported $7.15 revenue$19,109,000,000

Revenues $19.109B, net income $1.620B (+0.6% YoY); diluted EPS $7.15 (+10.9% YoY).
Adjusted EBITDA $3.802B (+1.9%); cash from operations $2.014B (+22.0%).
Same facility admissions +0.9%; equivalent admissions +1.3% vs Q1 2025.
Quarterly cash dividend of $0.78 per share declared, payable June 30, 2026 to holders of record June 16, 2026.

item 2.02 item 7.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.99

HCA Healthcare, Inc. reported first quarter ended March 31, 2026 results: revenue $19.109 billion, net income $1.620 billion, EPS $7.15 per diluted share.

Period: first quarter ended March 31, 2026
Revenue: $19.109 billion
Net income: $1.620 billion
EPS: $7.15 per diluted share
Result: reported results

Exact text from the filing

the first quarter ended March 31, 2026. Key first quarter metrics (all percentage changes compare 1Q 2026 to 1Q 2025 unless otherwise noted): • Revenues increased 4.3 percent to $19.109 billion • Net income attributable to HCA Healthcare, Inc. increased 0.6 percent to $1.620 billion • Diluted earnings per share and diluted earnings per share, as adjusted, increased 10.9

View on SEC.gov

1341 earnings releases filed in the last 30 days. Browse all earnings releases →

HCA Healthcare, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-174933

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.